Sugerencias
Idioma
Guía para autores
Buscador
Información de la revista
Vol. 50. Núm. 9.
(Septiembre 2026)
Cita
Cita
Compartir
Descargar PDF
Más opciones de artículo
Visitas
977
Vol. 50. Núm. 9.
(Septiembre 2026)
Update In intensive care medicine: Critical cancer patients

Acute respiratory failure in the oncologic critical care population: Mechanisms, diagnosis, and evolving therapeutic strategies

Insuficiencia respiratoria aguda en pacientes oncológicos críticamente enfermos: mecanismos, diagnóstico y estrategias terapéuticas en evolución
Visitas
977
Nirmala Manjappachara, Dharani Narendrab, Joseph L. Natesb,
Autor para correspondencia
jlnates@mdanderson.org

Corresponding author.
a Department of Pulmonary Medicine, Rosalind Franklin University of Medicine and Science-Chicago Medical School, Chicago, IL, United States
b Department of Critical Care, Division of Anesthesiology, Critical Care and Pain Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Este artículo ha recibido
Información del artículo
Resumen
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Abstract

Cancer is the second leading cause of death and a significant global burden. Up to 5% of patients with malignancies develop critical illnesses requiring advance support in intensive care units (ICU) accounting for approximately 15%–20% of all admissions. Acute respiratory failure (ARF), the main cause of ICU admission, most often manifests as hypoxemia due to ventilation-perfusion mismatch, shunt physiology, and impaired alveolar-capillary gas transfer, although hypercapnia may occur when airway obstruction, respiratory muscle weakness, or central ventilatory drive impairment predominates. These commonly coexist and are driven by the combined effects of tumor burden, treatment-related lung injury, infection, and reduced host reserve, leading to complex and evolving patterns of respiratory failure. Despite the improvement in access, earlier interventions, and better medical care overall, it is still associated with higher mortality than in non-cancer patients. In this review, we briefly discuss the current understanding of ARF in cancer patients.

Keywords:
Acute respiratory failure
Cancer
Intensive care unit
Management
Outcomes
Resumen

El cáncer es la segunda causa principal de muerte y representa una carga significativa a nivel mundial. Hasta un 5% de los pacientes con neoplasias desarrollan enfermedades críticas que requieren soporte avanzado en unidades de cuidados intensivos, representando aproximadamente entre el 15% y el 20% de todas las admisiones. La falla respiratoria aguda, principal causa de ingreso a las unidades, suele manifestarse como hipoxemia debida a alteraciones de la relación ventilación-perfusión y deterioro del intercambio gaseoso alveolocapilar entre otras, aunque también puede presentarse hipercapnia cuando predominan la obstrucción de la vía aérea, la debilidad de los músculos respiratorios o la alteración del centro ventilatorio central. A pesar de las mejoras en el acceso, las intervenciones tempranas y la atención médica en general, esta condición aún se asocia con una mayor mortalidad en comparación con los pacientes sin cáncer. En esta revisión, se analiza brevemente el conocimiento actual de esta condición.

Palabras clave:
Falla respiratoria aguda
Cáncer
Unidad de cuidados intensivos
Manejo
Resultados clínicos

Artículo

Opciones para acceder a los textos completos de la publicación Medicina Intensiva
Socio
Si es usted socio de la Sociedad Española de Medicina Intensiva, Crítica y Unidades Coronarias:
Diríjase al área de socios de la web de la SEMICYUC (www.semicyuc.org ) y pulse el enlace a la revista.
Suscriptor
Suscriptor de la revista

Si ya tiene sus datos de acceso, clique aquí.

Si olvidó su clave de acceso puede recuperarla clicando aquí y seleccionando la opción "He olvidado mi contraseña".
Suscribirse
Suscribirse a:
Medicina Intensiva
Comprar
Comprar acceso al artículo

Comprando el artículo el PDF del mismo podrá ser descargado

Comprar ahora
Contactar
Teléfono para suscripciones e incidencias
De lunes a viernes de 9h a 18h (GMT+1) excepto los meses de julio y agosto que será de 9 a 15h
Llamadas desde España
932 415 960
Llamadas desde fuera de España
+34 932 415 960
Email
References
[2]
J.L. Nates, M. Nunnally, R. Kleinpell, et al.
ICU admission, discharge, and triage guidelines: a framework to enhance clinical operations, development of institutional policies, and further research.
Crit Care Med, 44 (2016),
[3]
É. Azoulay, G. Thiéry, S. Chevret, et al.
The prognosis of acute respiratory failure in critically ill cancer patients.
Medicine (Baltimore), 83 (2004), pp. 360-370
[4]
E. Azoulay, D. Mokart, F. Pène, et al.
Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium–a groupe de recherche respiratoire en réanimation onco-hématologique study.
J Clin Oncol, 31 (2013), pp. 2810-2818
[5]
M.G. Kiehl, G. Beutel, B. Böll, et al.
Consensus statement for cancer patients requiring intensive care support.
Ann Hematol, 97 (2018), pp. 1271-1282
[6]
C. Constantinescu, V. Moisoiu, B. Tigu, D. Kegyes, C. Tomuleasa.
Outcomes of CAR-T cell therapy recipients admitted to the ICU: in search for a standard of care—a brief overview and meta-analysis of proportions.
J Clin Med, 12 (2023), pp. 6098
[7]
F.D. Martos-Benítez, C.D. Soler-Morejón, K.X. Lara-Ponce, et al.
Critically ill patients with cancer: a clinical perspective.
World J Clin Oncol, 11 (2020), pp. 809-835
[8]
N.K. Manjappachar, J.A. Cuenca, C.M. Ramírez, et al.
Outcomes and predictors of 28-day mortality in patients with hematologic malignancies and septic shock defined by sepsis-3 criteria.
J Natl Compr Canc Netw, 20 (2022), pp. 45-53
[9]
D. Chean, D. Luque-Paz, D. Poole, et al.
Critically ill adult patients with acute leukemia: a systematic review and meta-analysis.
Ann Intensive Care, 15 (2025), pp. 9
[10]
K. Puxty, P. McLoone, T. Quasim, B. Sloan, J. Kinsella, D.S. Morrison.
Risk of critical illness among patients with solid cancers: a population-based observational study.
JAMA Oncol, 1 (2015), pp. 1078-1085
[11]
E. Azoulay, D. Mokart, A. Kouatchet, A. Demoule, V. Lemiale.
Acute respiratory failure in immunocompromised adults.
Lancet Respir Med, 7 (2019), pp. 173-186
[12]
J.A. Cuenca, N.K. Manjappachar, C.M. Ramírez, et al.
Outcomes and predictors of 28-day mortality in patients with solid tumors and septic shock defined by Third International Consensus Definitions for Sepsis and Septic Shock Criteria.
Chest, 162 (2022), pp. 1063-1073
[13]
K. Heybati, J. Deng, A. Bhandarkar, et al.
Outcomes of acute respiratory failure in patients with cancer in the United States.
Mayo Clin Proc, 99 (2024), pp. 578-592
[14]
B.L. Ferreyro, D.C. Scales, H. Wunsch, et al.
Critical illness in patients with hematologic malignancy: a population-based cohort study.
Intensive Care Med, 47 (2021), pp. 1104-1114
[15]
E. Azoulay, P. Schellongowski, M. Darmon, et al.
The Intensive Care Medicine research agenda on critically ill oncology and hematology patients.
Intensive Care Med, 43 (2017), pp. 1366-1382
[16]
V. Lemiale, M. Resche-Rigon, D. Mokart, et al.
High-flow nasal cannula oxygenation in immunocompromised patients with acute hypoxemic respiratory failure: a Groupe de Recherche Respiratoire en Réanimation Onco-Hématologique Study.
Crit Care Med, 45 (2017), pp. e274-e280
[17]
S. Benguerfi, G. Dumas, M. Soares, et al.
Etiologies and outcome of patients with solid tumors admitted to ICU with acute respiratory failure: a secondary analysis of the EFRAIM study.
Respir Care, 68 (2023), pp. 740-748
[18]
E. Azoulay, J. Maertens, V. Lemiale.
How I manage acute respiratory failure in patients with hematological malignancies.
Blood, 143 (2024), pp. 971-982
[19]
E. Kampouri, C.S. Walti, J. Gauthier, J.A. Hill.
Managing hypogammaglobulinemia in patients treated with CAR-T-cell therapy: key points for clinicians.
Expert Rev Hematol, 15 (2022), pp. 305-320
[20]
Y. Ito, A. Honda, M. Kurokawa.
COVID-19 mRNA vaccine in patients with lymphoid malignancy or anti-CD20 antibody therapy: a systematic review and meta-analysis.
Clin Lymphoma Myeloma Leuk, 22 (2022), pp. e691-e707
[21]
J.L. Wong, S.E. Evans.
Bacterial pneumonia in patients with cancer: novel risk factors and management.
Clin Chest Med, 38 (2017), pp. 263-277
[22]
K. Ho, J. Gordon, K.T. Litzenberg, M.C. Exline, J.A. Englert, D.D. Herman.
Cancer is an independent risk factor for acute respiratory distress syndrome in critically ill patients: a single center retrospective cohort study.
J Intensive Care Med, 37 (2022), pp. 385-392
[23]
P. Schellongowski, M. Darmon, P. Eller, et al.
Acute respiratory distress syndrome in patients with cancer: the YELENNA prospective multinational observational cohort study.
Intensive Care Med, 51 (2025), pp. 1809-1819
[24]
D.E. Ost, S.C. Jim Yeung, L.T. Tanoue, M.K. Gould.
Clinical and organizational factors in the initial evaluation of patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Chest, 143 (2013), pp. e121S-e141S
[25]
W. Yu, Y. Shi, Q. Zheng, et al.
Comparison between community-acquired pneumonia and post-obstructive pneumonia associated with endobronchial tumors.
BMC Pulm Med, 24 (2024), pp. 589
[26]
F. Cervantes Requena, J. Costa Roma, et al.
[Carcinomatous lymphangitis of the lung. Report of 21 cases (author’s transl)].
Med Clin (Barc), 72 (1979), pp. 231-235
[27]
D. Feller-Kopman, R. Light.
Pleural disease.
N Engl J Med, 378 (2018), pp. 740-751
[28]
N.K. Rathi, A.R. Tanner, A. Dinh, et al.
Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage.
Bone Marrow Transplant, 50 (2015), pp. 420-426
[29]
C. Gutierrez, C. McEvoy, L. Munshi, et al.
Critical care management of toxicities associated with targeted agents and immunotherapies for cancer.
Crit Care Med, 48 (2020), pp. 10-21
[30]
S. Braude, J. Apperley, T. Krausz, J.M. Goldman, D. Royston.
Adult respiratory distress syndrome after allogeneic bone-marrow transplantation: evidence for a neutrophil-independent mechanism.
Lancet, 1 (1985), pp. 1239-1242
[31]
A. Panoskaltsis-Mortari, M. Griese, D.K. Madtes, et al.
An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome.
Am J Respir Crit Care Med, 183 (2011), pp. 1262-1279
[32]
B.L. Ferreyro, A.D. Law, L. Munshi.
Acute respiratory distress syndrome following hematopoietic stem cell transplantation: one more piece in the puzzle.
Ann Am Thorac Soc, 18 (2021), pp. 950-952
[33]
S. Herasevich, R.D. Frank, H. Bo, et al.
Pretransplant risk factors can predict development of acute respiratory distress syndrome after hematopoietic stem cell transplantation.
Ann Am Thorac Soc, 18 (2021), pp. 1004-1012
[34]
L. Munshi, M. Darmon, M. Soares, et al.
Acute respiratory failure outcomes in patients with hematologic malignancies and hematopoietic cell transplant: a secondary analysis of the EFRAIM study.
Transplant Cell Ther, 27 (2021), pp. 78.e1-.e6
[35]
E. Azoulay, V. Lemiale, D. Mokart, et al.
Acute respiratory distress syndrome in patients with malignancies.
Intensive Care Med, 40 (2014), pp. 1106-1114
[36]
B.T. Murphy, J.J. Mackrill, K.D. O’Halloran.
Impact of cancer cachexia on respiratory muscle function and the therapeutic potential of exercise.
J Physiol, 600 (2022), pp. 4979-5004
[37]
E. Azoulay, P. Pickkers, M. Soares, et al.
Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study.
Intensive Care Med, 43 (2017), pp. 1808-1819
[38]
D. Schnell, J. Mayaux, J. Lambert, et al.
Clinical assessment for identifying causes of acute respiratory failure in cancer patients.
Eur Respir J, 42 (2013), pp. 435-443
[39]
A.F. Shorr, G.M. Susla, N.P. O’Grady.
Pulmonary infiltrates in the non-HIV-infected immunocompromised patient: etiologies, diagnostic strategies, and outcomes.
Chest, 125 (2004), pp. 260-271
[40]
Y. Kunihiro, N. Tanaka, R. Kawano, et al.
Differential diagnosis of pulmonary infections in immunocompromised patients using high-resolution computed tomography.
Eur Radiol, 29 (2019), pp. 6089-6099
[41]
T. Johkoh, K.S. Lee, M. Nishino, et al.
Chest CT diagnosis and clinical management of drug-related pneumonitis in patients receiving molecular targeting agents and immune checkpoint inhibitors: a position paper from the Fleischner Society.
CHEST, 159 (2021), pp. 1107-1125
[42]
L. Calvet, V. Lemiale, D. Mokart, et al.
Interpretation of results of PCR and B-D-glucan for the diagnosis of Pneumocystis Jirovecii pneumonia in immunocompromised adults with acute respiratory failure.
Ann Intensive Care, 14 (2024), pp. 120
[43]
M.W. Bloom, J.B. Vo, J.E. Rodgers, et al.
Cardio-oncology and heart failure: a scientific statement from the Heart Failure Society of America.
J Cardiac Fail, 31 (2025), pp. 415-455
[44]
R.J. Shao, M.J. Du, J.T. Xie.
Use of lung ultrasound for the diagnosis and treatment of pleural effusion.
Eur Rev Med Pharmacol Sci, 26 (2022), pp. 8771-8776
[45]
G.R. Thompson 3rd, J.H. Young.
Aspergillus Infections.
N Engl J Med, 385 (2021), pp. 1496-1509
[46]
V. Gali, R. Al-Ghanamah, K. Finnigan, et al.
Evaluating the clinical utility of Aspergillus, Mucorales, and Nocardia bronchoalveolar PCRs for the diagnosis of invasive pulmonary infections in patients with hematological malignancies.
J Clin Microbiol, 63 (2025),
[47]
P.R. Bauer, S. Chevret, H. Yadav, et al.
Diagnosis and outcome of acute respiratory failure in immunocompromised patients after bronchoscopy.
Eur Respir J, 54 (2019),
[48]
V.R. Shannon, B.S. Andersson, X. Lei, R.E. Champlin, D.P. Kontoyiannis.
Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation.
Bone Marrow Transplant, 45 (2010), pp. 647-655
[49]
M.O. Al-Qadi, R. Cartin-Ceba, R. Kashyap, S. Kaur, S.G. Peters.
The diagnostic yield, safety, and impact of flexible bronchoscopy in non-HIV immunocompromised critically ill patients in the Intensive Care Unit.
Lung, 196 (2018), pp. 729-736
[50]
K. Jahn, M. Karakioulaki, D.M. Schumann, et al.
Impact of bronchoalveolar lavage on the management of immunocompromised hosts.
Eur J Intern Med, 120 (2024), pp. 52-61
[51]
A. Rañó, C. Agustí, P. Jimenez, et al.
Pulmonary infiltrates in non-HIV immunocompromised patients: a diagnostic approach using non-invasive and bronchoscopic procedures.
Thorax, 56 (2001), pp. 379-387
[52]
M.H. Bourne Jr., M.S. Norton, D.E. Midthun, et al.
Utility of transbronchial biopsy in the immunocompromised host with new pulmonary radiographic abnormalities.
Mayo Clin Proc, 96 (2021), pp. 1500-1509
[53]
N.K. Rathi, S.A. Haque, R. Nates, et al.
Noninvasivepositive pressure ventilation vsinvasive mechanical ventilation as first-line therapy for acute hypoxemic respiratory failure in cancer patients.
J Crit Care, 39 (2017), pp. 56-61
[54]
G. Dumas, V. Lemiale, N. Rathi, et al.
Survival in immunocompromised patients ultimately requiring invasive mechanical ventilation: a pooled individual patient data analysis.
Am J Respir Crit Care Med, 204 (2021), pp. 187-196
[55]
W. van den Boom, M. Hoy, J. Sankaran, et al.
The search for optimal oxygen saturation targets in critically ill patients: observational data from large ICU databases.
[56]
H.J. Helmerhorst, D.L. Arts, M.J. Schultz, et al.
Metrics of arterial hyperoxia and associated outcomes in critical care.
Crit Care Med, 45 (2017), pp. 187-195
[57]
J. Helms, P. Catoire, L. Abensur Vuillaume, et al.
Oxygen therapy in acute hypoxemic respiratory failure: guidelines from the SRLF-SFMU consensus conference.
Ann Intensive Care, 14 (2024), pp. 140
[58]
B.R. O’Driscoll, L.S. Howard, J. Earis, V. Mak.
British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings.
BMJ Open Respir Res, 4 (2017),
[59]
M. Girardis, S. Busani, E. Damiani, et al.
Effect of conservative vs conventional oxygen therapy on mortality among patients in an Intensive Care Unit: the Oxygen-ICU randomized clinical trial.
Jama, 316 (2016), pp. 1583-1589
[60]
G. Freitas Valverde, B. Prata Martinez, D. Gusmão Flôres, et al.
Conservative versus liberal oxygen therapy in mechanically ventilated patients: a systematic review with meta-analysis.
Can J Respir Ther, 61 (2025), pp. 1-11
[61]
F.E. Blum, E.T. Lund, H.A. Hall, A.D. Tachauer, E.G. Chedrawy, J. Zilberstein.
Reevaluation of the utilization of arterial blood gas analysis in the Intensive Care Unit: effects on patient safety and patient outcome.
J Crit Care, 30 (2015), pp. 438.e1-5
[62]
M. Patout, B. Lamia, E. Lhuillier, et al.
A randomized controlled trial on the effect of needle gauge on the pain and anxiety experienced during radial arterial puncture.
PLoS One, 10 (2015),
[63]
G. Hilbert, D. Gruson, F. Vargas, et al.
Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure.
N Engl J Med, 344 (2001), pp. 481-487
[64]
C. Sreenan, R.P. Lemke, A. Hudson-Mason, H. Osiovich.
High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure.
Pediatrics, 107 (2001), pp. 1081-1083
[65]
E. Rezoagli, A. Nova, G. Carteaux, et al.
A clinical guide to non-invasive respiratory support in acute respiratory failure: ventilation settings, technical optimization and clinical indications.
[66]
M. Maimaitiniyazi, T. Yisimitila, M. Maimaitiniyazi, et al.
Meta-analysis of high-flow nasal cannula oxygen therapy versus non-invasive ventilation after invasive mechanical ventilation.
Front Med (Lausanne), 12 (2025),
[67]
B.L. Ferreyro, F. Angriman, L. Munshi, et al.
Association of noninvasive oxygenation strategies with all-cause mortality in adults with acute hypoxemic respiratory failure: a systematic review and meta-analysis.
[68]
D.L. Grieco, S.M. Maggiore, O. Roca, et al.
Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS.
Intensive Care Med, 47 (2021), pp. 851-866
[69]
Y.M. Arabi, S. Aldekhyl, S. Al Qahtani, et al.
Effect of helmet noninvasive ventilation vs usual respiratory support on mortality among patients with acute hypoxemic respiratory failure due to COVID-19: the HELMET-COVID randomized clinical trial.
Jama, 328 (2022), pp. 1063-1072
[70]
I. Ahmad, K. El-Boghdadly, H. Iliff, et al.
Difficult Airway Society 2025 guidelines for management of unanticipated difficult tracheal intubation in adults.
Br J Anaesth, (2025),
[71]
P.S. Bramati, A. Azhar, R. Khan, et al.
High flow nasal cannula in patients with cancer at the end of life.
J Pain Symptom Manage, 65 (2023), pp. e369-e373
[72]
Y. Perez, J. Luo, M. Ibarra-Estrada, J. Li, S. Ehrmann.
Awake prone positioning for patients with COVID-19-induced acute hypoxemic respiratory failure.
J Intensive Med, 2 (2022), pp. 233-240
[73]
S. Ehrmann, J. Li, M. Ibarra-Estrada, et al.
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial.
Lancet Respir Med, 9 (2021), pp. 1387-1395
[74]
W. Alhazzani, K.K.S. Parhar, J. Weatherald, et al.
Effect of awake prone positioning on endotracheal intubation in patients with COVID-19 and acute respiratory failure: a randomized clinical trial.
Jama, 327 (2022), pp. 2104-2113
[75]
M. Fralick, M. Colacci, L. Munshi, et al.
Prone positioning of patients with moderate hypoxaemia due to covid-19: multicentre pragmatic randomised trial (COVID-PRONE).
Bmj, 376 (2022),
[76]
J. Luo, I. Pavlov, E. Tavernier, et al.
Awake prone positioning in adults with COVID-19: an individual participant data meta-analysis.
JAMA Intern Med, 185 (2025), pp. 572-581
[77]
E. Fan, L. Del Sorbo, E.C. Goligher, et al.
An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome.
Am J Respir Crit Care Med, 195 (2017), pp. 1253-1263
[78]
L. Munshi, L. Del Sorbo, N.K.J. Adhikari, et al.
Prone position for acute respiratory distress syndrome. A systematic review and meta-analysis.
Ann Am Thorac Soc, 14 (2017), pp. S280-s8
[79]
G. Grasselli, C.S. Calfee, L. Camporota, et al.
ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies.
Intensive Care Med, 49 (2023), pp. 727-759
[80]
J. Dianti, M. Tisminetzky, B.L. Ferreyro, et al.
Association of positive end-expiratory pressure and lung recruitment selection strategies with mortality in acute respiratory distress syndrome: a systematic review and network meta-analysis.
Am J Respir Crit Care Med, 205 (2022), pp. 1300-1310
[81]
M. Di Nardo, G. MacLaren, P. Schellongowski, et al.
Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement.
Lancet Respir Med, 11 (2023), pp. 477-492
[82]
H. Tong, F. Pan, X. Zhang, et al.
Effect of prone positioning on survival in adult patients receiving venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a prospective multicenter randomized controlled study.
J Thorac Dis, 16 (2024), pp. 1368-1377
[83]
U.D. Bayraktar, J.L. Nates.
Intensive care outcomes in adult hematopoietic stem cell transplantation patients.
World J Clin Oncol, 7 (2016), pp. 98-105
[84]
U.D. Bayraktar, E.J. Shpall, P. Liu, et al.
Hematopoietic cell transplantation-specific comorbidity index predicts inpatient mortality and survival in patients who received allogeneic transplantation admitted to the intensive care unit.
J Clin Oncol, 31 (2013), pp. 4207-4214
Idiomas
Medicina Intensiva
Opciones de artículo
Herramientas